| 1 |
Yu C, Wang S, Lai WF, Zhang D. The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment. Pharmaceutics 2023;15. [PMID: 36678840 DOI: 10.3390/pharmaceutics15010211] [Reference Citation Analysis]
|
| 2 |
de Lima CSA, Varca JPRO, Alves VM, Nogueira KM, Cruz CPC, Rial-hermida MI, Kadłubowski SS, Varca GHC, Lugão AB. Mucoadhesive Polymers and Their Applications in Drug Delivery Systems for the Treatment of Bladder Cancer. Gels 2022;8:587. [DOI: 10.3390/gels8090587] [Reference Citation Analysis]
|
| 3 |
Zeng S, Feng X, Xing S, Xu Z, Miao Z, Liu Q. Advanced Peptide Nanomedicines for Bladder Cancer Theranostics. Front Chem 2022;10:946865. [DOI: 10.3389/fchem.2022.946865] [Reference Citation Analysis]
|
| 4 |
Ashrafizadeh M, Zarrabi A, Karimi-Maleh H, Taheriazam A, Mirzaei S, Hashemi M, Hushmandi K, Makvandi P, Nazarzadeh Zare E, Sharifi E, Goel A, Wang L, Ren J, Nuri Ertas Y, Kumar AP, Wang Y, Rabiee N, Sethi G, Ma Z. (Nano)platforms in bladder cancer therapy: Challenges and opportunities. Bioeng Transl Med 2023;8:e10353. [PMID: 36684065 DOI: 10.1002/btm2.10353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 5 |
Moammeri A, Abbaspour K, Zafarian A, Jamshidifar E, Motasadizadeh H, Dabbagh Moghaddam F, Salehi Z, Makvandi P, Dinarvand R. pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Tumorigenesis Breast Cancer. ACS Appl Bio Mater 2022. [PMID: 35129960 DOI: 10.1021/acsabm.1c01107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 6 |
Zhang S, Li G, Deng D, Dai Y, Liu Z, Wu S. Fluorinated Chitosan Mediated Synthesis of Copper Selenide Nanoparticles with Enhanced Penetration for Second Near‐Infrared Photothermal Therapy of Bladder Cancer. Adv Therap 2021;4:2100043. [DOI: 10.1002/adtp.202100043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 7 |
Li G, He S, Schätzlein AG, Weiss RM, Martin DT, Uchegbu IF. Achieving highly efficient gene transfer to the bladder by increasing the molecular weight of polymer-based nanoparticles. J Control Release 2021;332:210-24. [PMID: 33607176 DOI: 10.1016/j.jconrel.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Deng S, Gigliobianco MR, Censi R, Di Martino P. Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities. Nanomaterials (Basel) 2020;10:E847. [PMID: 32354008 DOI: 10.3390/nano10050847] [Cited by in Crossref: 78] [Cited by in F6Publishing: 88] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 9 |
Jia YY, Zhang JJ, Zhang YX, Wang W, Li C, Zhou SY, Zhang BL. Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy. Int J Pharm 2020;580:119190. [PMID: 32151664 DOI: 10.1016/j.ijpharm.2020.119190] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 10 |
Wang B, Zhang K, Wang J, Zhao R, Zhang Q, Kong X. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy. Colloids Surf B Biointerfaces 2020;189:110832. [PMID: 32070865 DOI: 10.1016/j.colsurfb.2020.110832] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 11 |
Kerec Kos M, Veranič P, Erman A. Poly-L-lysine as an Effective and Safe Desquamation Inducer of Urinary Bladder Epithelium. Polymers (Basel) 2019;11:E1506. [PMID: 31527451 DOI: 10.3390/polym11091506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Zarepour A, Zarrabi A, Larsen KL. Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy. Int J Nanomedicine 2019;14:7017-38. [PMID: 31564863 DOI: 10.2147/IJN.S221598] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Mullapudi SS, Zhang J, Lu S, Rahmat JN, Mahendran R, Kang E, Chiong E, Neoh KG. Receptor-Targeting Drug and Drug Carrier for Enhanced Killing Efficacy against Non-Muscle-Invasive Bladder Cancer. ACS Appl Bio Mater 2019;2:3763-73. [DOI: 10.1021/acsabm.9b00403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Carvalho I, Miranda M, Silva L, Chrysostomo-massaro T, Paschoal J, Bastos J, Marcato P. IN VITRO Anticancer Activity and Physicochemical Properties of SOLANUM LYCOCARPUM Alkaloidic Extract Loaded in Natural Lipid-Based Nanoparticles. Colloid and Interface Science Communications 2019;28:5-14. [DOI: 10.1016/j.colcom.2018.11.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 15 |
Zhukova OV. Polymer Derivatives of Anticancer Drugs: Features of Synthesis and Biological Activity. Ref J Chem 2019;9:1-11. [DOI: 10.1134/s2079978019010011] [Reference Citation Analysis]
|
| 16 |
Kolawole OM, Lau WM, Khutoryanskiy VV. Methacrylated chitosan as a polymer with enhanced mucoadhesive properties for transmucosal drug delivery. Int J Pharm 2018;550:123-9. [PMID: 30130604 DOI: 10.1016/j.ijpharm.2018.08.034] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 17 |
Crijnen J, De Reijke TM. Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer. Expert Opin Emerg Drugs 2018;23:135-47. [PMID: 29730950 DOI: 10.1080/14728214.2018.1474201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 18 |
Buss JH, Begnini KR, Bender CB, Pohlmann AR, Guterres SS, Collares T, Seixas FK. Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer. Front Pharmacol 2017;8:977. [PMID: 29379438 DOI: 10.3389/fphar.2017.00977] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 19 |
Charbgoo F, Alibolandi M, Taghdisi SM, Abnous K, Soltani F, Ramezani M. MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide. Nanomedicine 2018;14:685-97. [PMID: 29317345 DOI: 10.1016/j.nano.2017.12.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 20 |
Wang L, Zhou Y, Wu M, Wu M, Li X, Gong X, Chang J, Zhang X. Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues. Nanomedicine (Lond) 2018;13:69-88. [PMID: 29173025 DOI: 10.2217/nnm-2017-0143] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 21 |
Franco MS, Oliveira MC. Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy. Biomed Pharmacother 2017;96:584-95. [PMID: 29035823 DOI: 10.1016/j.biopha.2017.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Uivarosi V, Olar R, Badea M. Nanoformulation as a Tool for Improve the Pharmacological Profile of Platinum and Ruthenium Anticancer Drugs. Descriptive Inorganic Chemistry Researches of Metal Compounds 2017. [DOI: 10.5772/intechopen.68306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Guo H, Xu W, Chen J, Yan L, Ding J, Hou Y, Chen X. Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma. Journal of Controlled Release 2017;259:136-48. [DOI: 10.1016/j.jconrel.2016.12.041] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 24 |
Kaufmann A, Hampel S, Rieger C, Kunhardt D, Schendel D, Füssel S, Schwenzer B, Erdmann K. Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubes. J Nanobiotechnology 2017;15:53. [PMID: 28716122 DOI: 10.1186/s12951-017-0288-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 25 |
Surnar B, Jayakannan M. Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs. Biomacromolecules 2016;17:4075-85. [PMID: 27936725 DOI: 10.1021/acs.biomac.6b01608] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 26 |
Yostawonkul J, Surassmo S, Iempridee T, Pimtong W, Suktham K, Sajomsang W, Gonil P, Ruktanonchai UR. Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier. Colloids Surf B Biointerfaces 2017;149:301-11. [PMID: 27780087 DOI: 10.1016/j.colsurfb.2016.09.049] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 27 |
Li H, Yu H, Zhu C, Hu J, Du M, Zhang F, Yang D. Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery. RSC Adv 2016;6:94160-9. [DOI: 10.1039/c6ra17213j] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
|
